Back to ADA 2004 Selected Abstracts from ADA 2004

Posters and oral presentations at the ADA's Scientific Sessions offer attendees a chance to learn about advances in diabetes research and care. Here are links to selected abstracts for posters and oral presentations for the 2004 Scientific Sessions.

  1. Continuous Sensing and Blood Glucose Monitoring

    1. Statistically-Fitted Curve for A1c as a Function of the SMBG Tests Per Day.

    2. Postprandial CGMS Values Are Strong Predictors of HbA1c.

    3. Accuracy Evaluation of the FreeStyle Navigator Continuous Glucose Monitor Detection of Hypoglycemia.

    4. Clinical Utility of the FreeStyle Navigator Continuous Glucose Monitor.

    5. Accuracy of the Guardian Continuous Monitoring System under Conditions of Normal Use.

    6. Alarms Based on Real-Time Sensor Glucose Values Alert Patients to Hypo- and Hyperglycemia and Reduce Glycemic Excursions: Results of a Randomized Multicenter Study.

    7. Accuracy of the Non-Invasive Glucose Monitoring Device Pendra Compared to Alternate Site Testing at the Lower Forearm during Dynamic Blood Glucose Changes in Type 1 Diabetic Patients.

    8. A Comparison of the Original vs. Modified Continuous Glucose Monitoring System (CGMS) Sensor Using Data from Two DirecNet Studies.

    9. Clinical Utility of the Continuous Glucose Monitoring System (CGMS) in Patients with Type 1 Diabetes (T1DM).

    10. Comparison of 8-Point Glucose Testing with Glycemic Control in Children with Type 1 Diabetes (T1DM).

    11. Evaluating the Upper Arm and the Abdomen Sites for the Continuous Monitoring of Interstitial Fluid Glucose Concentration.

    12. Extended Use of a New CGMS Glucose Sensor with Wireless Data Transmission.

    13. Functionality of the MiniMed Continuous Glucose Monitoring System (CGMS) in Young Children with Type 1 Diabetes.

    14. The Medtronic MiniMed Paradigm 522 Continuous Glucose Monitoring System for Patient Use: Real-Time Sensor Glucose Values.

    15. Comparison of Test Strip Stability for Four Blood Glucose Monitoring Systems.

  2. Pump Therapy

    1. Higher Number of Daily Boluses Is Associated with Lower Glycosylated HbA1c in a Cohort of 370 Children and Adolescents Treated with Continuous Subcutaneous Insulin Infusion.

    2. Aspart and Lyspro Insulin, Are There Any Differences When Used with an Insulin Pump Treatment? A Randomised, Cross-Over Study, on Daytime Glycaemic Variability, Using the Continuous Glucose Monitoring System (CGMS).

    3. Accuracy of Repeated Meal Carbohydrate Content Estimation by Type 1 Diabetics with CSII.

    4. Baseline A1c Determines Efficacy of Insulin Pump Therapy: A Pooled Analysis of Studies of Continuous Subcutaneous Insulin Infusion vs Multiple Daily Injection Regimens Using Rapid-Acting Insulin Analogues.

    5. Continuous Automated Insulin Delivery Based on Subcutaneous Glucose Sensing and an External Insulin Pump.

    6. Precipitation of Insulin Products Used for Continuous Subcutaneous Insulin Infusion (CSII).

    7. Prospective Study of Quality of Life in Children Treated with the Insulin Pump.

    8. Safety of Insulin Glulisine Compared with Insulin Aspart Administered by Continuous Subcutaneous Insulin Infusion (CSII).

    9. Transitioning Patients with Type 1 Diabetes from Multiple Daily Injections (MDI) to Continuous Subcutaneous Insulin Infusion (CSII).

    10. User Responses to a New Smart Insulin Pump and Personal Computer Based Treatment Assistant.

  3. Insulins and Other Hormones in Type 1

    1. Glycemic Control Unaffected by Mixing Glargine with Short Acting Insulin Analogues.

    2. A Comparison of the Cost-Effectiveness for Basal-Bolus Therapy of Type 1 Diabetes Using Insulin Detemir+Insulin Aspart or Human Insulin-Based Regimens.

    3. Basal/Bolus Regimen Using Insulin Glargine and Rapid-Acting Insulin Analogs in Children <6 Years of Age: A Clinical Experience in a Large Urban Practice.

    4. Benefits of Insulin Detemir over NPH Insulin in Children and Adolescents with Type 1 Diabetes: Lower and More Predictable Fasting Plasma Glucose and Lower Risk of Nocturnal Hypoglycemia.

    5. Comparison of a Multiple Daily Injection Regimen with Once-Daily Insulin Glargine Basal Insulin and Mealtime Lispro, to Continuous Subcutaneous Insulin Infusion: A Randomised, Open, Parallel Study.

    6. Efficacy and Safety of Insulin Glulisine (GLU) and Insulin Lispro (IL), Combined with Insulin Glargine (GLAR) in Patients with Type 1 Diabetes.

    7. Flexible Insulin Therapy with Glargine Insulin in Pre-School Children with Type 1 Diabetes Mellitus.

    8. Insulin Glargine Use in Children and Adolescents.

    9. Is Twice-Daily Insulin Glargine Superior to Once-Daily Administration?

    10. Long-Term Treatment with Insulin Glargine in Children and Adolescents with Type 1 Diabetes Improves Glycemic Control.

    11. Optimal Timing of Injection of Once-Daily Insulin Glargine in People with Type 1 Diabetes Using Insulin Lispro at Meal-Times.

    12. Reduced Severe Hypoglycemia (SH) in Children under Age 6 with Type 1 Diabetes Treated with Insulin Glargine.

    13. Similar Glycemic Profiles with Dinner or Bedtime Insulin Glargine in Type 1 Diabetes.

    14. Sustained Long-Term Efficacy and Safety of Inhaled Insulin during 4 Years of Continuous Therapy.

    15. Assessing Glucose Variability Using CGMS in Pramlintide- and Placebo-Treated Subjects with Type 1 Diabetes Mellitus.

    16. Patients with Type 1 Diabetes: Perceptions Associated with Pramlintide as an Adjunctive Treatment to Insulin.

  4. Diabetes in Children

    1. The Direct Medical Cost of Diabetes in Children.

    2. Are Younger Children with Type 1 Diabetes so Different from Adolescents?

    3. BG Detection in School-Aged Children with T1DM and Their Parents.

    4. Concerns of Parents about Their Children's Diabetes Care in Schools.

    5. STAR: A Group Mentoring Program for Type 1 Diabetes Mellitus (T1DM) Adolescents and Their Parents in a Rural Setting.

    6. Effect of Family Environment on Anxiety in Children with Type 1 Diabetes.

    7. Depression in Adolescents with Diabetes.

    8. A Comparison of Two Clinical Indices of Biological Variation in Glycated Hemoglobin Level from Pediatric Patients with Type 1 Diabetes.

    9. Bringing Fun to Type-1 Diabetes Education: An Edutainment Approach.

    10. Increased Incidence and Severity of Diabetic Ketoacidosis among Uninsured Children with Newly Diagnosed Type 1 Diabetes.

    11. Prevalence of Eating Disturbances in Young Patients with Type 1 Diabetes.

  5. Celiac Disease

    1. Celiac Disease in Type 1 Diabetes: Screening and Follow-Up.

    2. Celiac Disease in a Cohort of 400 Patients with Type 1 Diabetes. A Prospective Study.

  6. Exercise and Sports

    1. A New Method To Predict Carbohydrate Needs for Diabetics during Exercise.

    2. A 10-Second Sprint Acutely Prevents an Exercise-Mediated Decrease in Glycemia in Individuals with Type 1 Diabetes Mellitus.

    3. Effects of Exercise on the Absorption of Insulin Glargine in Persons with Type 1 Diabetes Mellitus.

    4. The Risk of Hypoglycemia Is Not Increased during Early Recovery from Intermittent High-Intensity Exercise in Individuals with Type 1 Diabetes Mellitus.

  7. Complications and Hypoglycemia

    1. The Impact of Acute Hypoglycaemia on Cognitive Functioning in Adolescents with Type 1 Diabetes (T1DM): Nonuniform Effects?

    2. Influence of Caffeine on Frequency of Hypoglycaemia Detected by a Continuous Interstitial Glucose Monitoring System in Patients with Long-Standing Type 1 Diabetes.

    3. Age-Induced Blood Pressure Changes in Type 1 Diabetes.

    4. A-Tocopherol Reduces Diabetes-Induced Retinal Vascular Leakage and ERG Abnormalities in the Rat.

    5. A New Topical Medication for the Adjunctive Relief of Painful Diabetic Neuropathy.

    6. A Shocking Solution to Diabetic Gastroparesis: Enterra. The Community Experience.

    7. Spontaneous Biochemical Nocturnal Hypoglycemia in Type 1 Diabetes Is Associated with an Increased Risk of Hypoglycemia the Following Day.

  8. Obesity and Type 2 Diabetes

    1. Adolescent Obesity Is Associated with Excess Consumption of Diet Soda.

  9. Other

    1. A New Mental Health Competency Tool Demontrates a Significant Relationship with HbA1c in a Pilot Camp Study.

    2. The "Euglycemic Diet" Facilitates Euglycemia with Less Insulin in Persons with Type 1 Diabetes (T1DM).

    3. Risk Factors for Driving Mishaps among Adults with T1DM.

  Back to ADA 2004 Return to the Top of This Page

Last Updated: Saturday May 22, 2004 20:29:48
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.